Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06351540
Other study ID # IRB00332797
Secondary ID R21DA056687
Status Not yet recruiting
Phase Phase 1
First received
Last updated
Start date August 1, 2024
Est. completion date December 1, 2025

Study information

Verified date April 2024
Source Johns Hopkins University
Contact Dustin C Lee, PhD
Phone 410-550-4035
Email dlee214@jhmi.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to determine the extent to which oculomotor function accurately detects THC-impairment, if cannabis use experience impacts this detection threshold, and to examine how the oculomotor index corresponds to a measure of sustained attention. A double-blind, placebo-controlled, within-subjects crossover design will be used to examine the dose-effects of THC (0, 5mg, 30mg) on oculomotor performance tasks and a sustained attention task in frequent and infrequent cannabis users. Results from the study will advance the investigators' understanding of the effect of THC and cannabis use frequency on oculomotor function and sustained attention, and will directly inform the validity of the investigators' oculomotor platform for identifying acute THC- induced impairment in frequent and infrequent users.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date December 1, 2025
Est. primary completion date August 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Inclusion criteria: Healthy non-treatment seeking adults (age 18 to 60, N = 40) who report - (a) infrequent cannabis use defined as at least one reported use in the past year with a negative THC urine toxicology at baseline, or - (b) report frequent cannabis use defined as > 5 days per week for > 1 year with a positive THC urine toxicology at baseline. These criteria were selected to target individuals with low and high-frequency cannabis use in order to examine the direct effect of tolerance on study outcome measures. Exclusion Criteria: - (1) meet DSM-V criteria for substance use disorders other than tobacco, cannabis, or caffeine, - (2) are currently receiving or interested in immediately receiving behavioral treatment or medication for cannabis cessation, - (3) current use of any medications that could affect study outcomes, - (4) test positive for drugs of abuse (other than cannabis) and/or breath alcohol test at study admission, - (5) have a current physical or mental illness judged by the study team to negatively impact participant safety or scientific integrity, - (6) are currently pregnant, planning to become pregnant in the next three months or are currently breastfeeding, - (7) have a history of clinically significant cardiac arrhythmias or vasospastic disease (e.g. Prinzmetal's angina), or (8) are currently enrolled in another clinical trial or have received any drug as part of a research study within 30 days of study participation.

Study Design


Intervention

Drug:
Cannabis
cannabis with 0, 5, or 30 mg THC will be inhaled via vaporization

Locations

Country Name City State
United States Johns Hopkins Behavioral Pharmacology Research Unit Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Commission Errors The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Commission errors is measured by calculating the number of trials participants incorrectly push the spacebar in the presence of "X" stimulus. pre-administration, post-administration, 2, 4 hours
Primary Omission Errors The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Omission errors is measured by calculating the number of trials participants fail to push the spacebar in the presence of a letter that is not an "X" stimulus. pre-administration, post-administration, 2, 4 hours
Primary Reaction Time The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Reaction time is measured by calculating the duration between the presentation of a letter other than "X", and the correct response of a spacebar push. pre-administration, post-administration, 2, 4 hours
Primary Reaction Time Standard Error The Conners Continuous Performance Test (CPT) will be used to assess sustained attention. Reaction time standard error is measured by calculating the standard error of the mean of the reaction time. pre-administration, post-administration, 2, 4 hours
Primary Visuomotor Index The visuomotor index score is calculated by mathematically integrating five measures of oculomotor fixation performance and two measures of accuracy into a single score during fixation and accuracy tasks, respectively. Test of visual fixation to measure microsaccades, spontaneous nystagmus, and gaze-evoked nystagmus. pre-administration, post-administration, 2, 4 hours
Secondary Saccade Speed Measures how quickly participants look back and forth between two spots as possible during the oculomotor task. Pre-administration, post-administration, 2, 4 hours
Secondary Visually Guided Oculomotor Performance Measures how quickly and accurately participants move their eyes to a cue as soon as it appears on the oculomotor task. Pre-administration, post-administration, 2, 4 hours
Secondary Antisaccade Measures voluntary eye movement in the direction opposite to the side in which a visual cue is presented. Pre-administration, post-administration, 2, 4 hours
Secondary Memory-Guided Measures how quickly gaze is shifted directly and accurately to a remembered cue position. Pre-administration, post-administration, 2, 4 hours
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Recruiting NCT04356924 - Psychological Treatment to Support the Consequences of Cognitive Impairment N/A
Suspended NCT05542238 - The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury N/A
Terminated NCT04493957 - Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT04426838 - Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad N/A
Completed NCT04713384 - Remote Bimanual Virtual Rehabilitation Post CVD N/A
Recruiting NCT06284213 - Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Recruiting NCT06053775 - Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP) N/A
Completed NCT03698695 - A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers Phase 1
Not yet recruiting NCT05552729 - Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors Phase 1/Phase 2
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT03301402 - Air Purifier to Improve Endothelial Function and Carotid Intima Thickness N/A
Completed NCT03187353 - IMProving Executive Function Study Phase 4
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Recruiting NCT04907565 - Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Recruiting NCT05030285 - Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment N/A